Non-Interventional Study to Establish Consensus on Management of Metastatic Hormone-Sensitive Prostate Cancer Patients

Clinical trial NCT06452212 · COMPLETED

Trial details

NCT number: NCT06452212
Sponsor: Astellas Pharma Korea, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Hormone-Sensitive Prostate Cancer

Start date: 2024-07-10
Primary completion: 2024-07-29
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.